SB 134

  • Kentucky Senate Bill
  • 2022 Regular Session
  • Introduced in Senate Feb 02, 2022
  • Senate
  • House
  • Governor

AN ACT relating to prescription drugs.

Abstract

Amend KRS 304.17A-164 to establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with the prescription drugs cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; create a new section of Subtitle 17C of KRS Chapter 304 to apply the cost-sharing and rebate requirements for prescription drugs to limited health service benefit plans and limited health service contracts; create a new section of Subtitle 38A of KRS Chapter 304 and amend KRS 18A.225 and 164.2871 to require limited health service organizations, the state employee health plan, and self-insured employer group health plans provided by the governing board of a state postsecondary education institution to comply with the cost-sharing and rebate requirements for prescription drugs; apply to health plans issued or renewed on or after the effective date of the Act; EFFECTIVE January 1, 2023.

Bill Sponsors (3)

Votes


No votes to display

Actions


Feb 07, 2022

Senate

to Banking & Insurance (S)

Feb 02, 2022

Senate

introduced in Senate

Senate

to Committee on Committees (S)

Bill Text

Bill Text Versions Format
Introduced PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Kentucky General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.